Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia

Cancer Immunity

Volumn 3, Issue , 2003, Pages 1-12

  Li, Li ^a   Schmitt, Anita ^a   Reinhardt, Peter ^a   Greiner, Jochen ^a   Ringhoffer, Mark ^a   Vaida, Bianca ^a   Bommer, Martin ^a   Vollmer, Markus ^a   Wiesneth, Markus ^a   Döhner, Hartmut ^a   Schmitt, Michael ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute myeloid leukemia; CD40; CD80; Dendritic cells; Human; Tumor antigens

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR3 ANTIGEN; LEUKEMIA ANTIGEN; MESSENGER RNA; PRAME ANTIGEN; RHAMM ANTIGEN; UNCLASSIFIED DRUG; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER IMMUNOTHERAPY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE CULTURE; MALE; T LYMPHOCYTE; UPREGULATION;

EID: 3042631406     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stockerl-Goldstein KG, Blume KG. Allogeneic hematopoietic cell transplantation for adult patients with acute myeloid leukemia. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic cell transplantation. 2nd ed. London: Blackwell Inc.; 1999. p. 823-834.
2. Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wormann B. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission. Leukemia 1999; 13: 386-392. (PMID: 10086729)
3. Vollmer M, Li L, Schmitt A, Greiner J, Reinhardt P, Ringhoffer M, Wiesneth M, Döhner H, Schmitt M. Expression of human leucocyte antigens and costimulatory antigens on blasts of patients with acute myeloid leukaemia. Br J Haematol 2003; 120: 1000-1008. (PMID: 12648070)
4. Janeway CA Jr, Travers P. Immunology: the immune system in health and disease. 4th ed. New York (NY): Garland Publishing Inc.; 1999.
5. Mazouz N, Ooms A, Moulin V, van Meirvenne S, Uyttenhove C, Degiovanni G. CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization. Cancer Immun 2002; 2: 2. (PMID: 12747747)
6. Banchereau J, Brière F, Caux C, Davoust J, Lebecque S, Liu YJ, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811. (PMID: 10837075)
7. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell 2001; 106: 271-274. (PMID: 11509176)
8. Grammer AC, Lipsky PE. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv Immunol 2000; 76: 61-178. (PMID: 11079098)
9. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118. (PMID: 8145033)
10. Cignetti A, Bryant E, Allione B, Vitale A, Foa R, Cheever MA. CD34+ acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 1999; 94: 2048-2055. (PMID: 10477734)
11. Kohler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhäuser M. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 2000; 18: 139-147. (PMID: 10742386)
12. Choudhury A, Liang JC, Thomas EK, Flores-Romo L, Xie QS, Agusala K, Sutaria S, Sinha I, Champlin RE, Claxton DF. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous antileukemic T cell responses. Blood 1999; 93: 780-786. (PMID: 9920826)
13. Choudhury A, Gajewski J, Liang J, Popat U, Claxton D, Kliche K, Andreeff M, Champlin R. Use of leukemic dendritic cells for the generation of anti-leukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997; 89: 1133-1142. (PMID: 9028934)
14. Choudhury A, Toubert A, Sutaria S, Charron D, Champlin R, Claxton D. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit Rev Immunol 1998; 18: 121-131. (PMID: 9419454)
15. Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997; 6: 199-208. (PMID: 9047241)
16. Oka Y, Udaka K, Tsuboi A, Elisseeva OA, Ogawa H, Aozasa K, Kishimoto T, Sugiyama H. Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J Immunol 2000; 164: 1873-1880. (PMID: 10657636)
17. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krähn G, Heilmann V, Gschwend J, Bergmann L, Döhner H, Schmitt M. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol 2002; 30: 1029-1035. (PMID: 12225794)
18. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000; 18: 245-273. (PMID: 10837059)
19. Murphy GP, Tjoa BA, Simmons SJ, Ragd H, Rogers M, Elgamal A, Kenny GM, Troychak MJ, Salgaller ML, Boynton AL. Phase II prostate cancer vaccine trial: report on a study involving 37 patients with disease recurrence after primary treatment. Prostate 1999; 39: 54-59. (PMID: 10221267)
20. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E, Schuler G. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190: 1669-1678. (PMID: 10587357)
21. Maurer U, Weidmann E, Karakas T, Hoelzer D, Bergmann L. Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors. Blood 1997; 90: 4230-4232. (PMID: 9354696)
22. Oka Y, Elisseeva OA, Tsuboi A, Ogawa H, Tamaki H, Li H, Oji Y, Kim EH, Soma T, Asada M, Ueda K, Maruya E, Saji H, Kishimoto T, Udaka K, Sugiyama H. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 2000; 51: 99-107. (PMID: 10663572)
23. Fröhling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Döhner H, Döhner K. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. Journal of Clinical Oncology 2002; 20: 2480-2485. (PMID: 12011125)
24. Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Maurer U, Bergmann L, Schmitt M. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 2000; 28: 1413-1422. (PMID: 11146163)
25. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Döhner H, Schmitt M. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer 2003; 106: 224-31. (PMID: 12800198)
26. Notter M, Willinger T, Erben U, Thiel E. Targeting of a B7(CD 80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. Blood 2001; 97: 3138-3145. (PMID: 11342441)
27. Reinhardt P, Schmitt M, Ringhoffer M, Greiner J, Maccari B, Schmitt A, Döhner H, Wiesneth M. Autologous dendritic cells for the treatment of patients with refractory acute myeloid leukemia. Onkologie 2002; 25 Suppl 4: 182 (abstract # 640).
28. Nestlé FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4: 328-332. (PMID: 9500607)
29. Brugger W, Brossart P, Scheding S, Stuhler G, Heinrich K, Reichardt V, Grunebach F, Buhring HJ, Kanz L. Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation. Ann N Y Acad Sci 1999; 872: 363-371. (PMID: 10372138)
30. Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of non-leukemic origin. Cancer Res 2002; 62: 2861-2868. (PMID: 12019165)